Cannabis Stocks Archives - Page 3 of 16

ThursdayFeb 06, 2025 10:00 am

Colorado Marijuana Firm’s Testing Experiment Reveals Extent of Pesticide, Microbial Contaminants

A recent review of Colorado’s recreational marijuana products has revealed that over 85% of the products sold by regulated cannabis retailers may violate labeling and health laws. An analysis conducted by one cannabis operator found a shocking amount of microbial and pesticide contaminants in a majority of retail adult-use products Colorado residents consume. In November 2024, Ripple CEO Justin Singer instructed his staffers to purchase cannabis pre-rolls, shakes, and flower from marijuana retailers in the Denver area. Singer was frustrated by the Colorado Marijuana Enforcement Division’s (MED) seeming reluctance to carry out its mandate of ensuring state-regulated marijuana products are…

TuesdayFeb 04, 2025 10:00 am

Missouri Courts Close to Completing Review of Marijuana Expungements

Missouri courts are close to completing their review of cannabis expungements after expunging hundreds of thousands of cannabis cases. The review began after Missouri voters approved a constitutional amendment to legalize adult use marijuana in 2022 and has seen state courts expunge over 300,000 cases. The amendment instructed Missouri courts to search their files for eligible cannabis-related offenses and permanently remove them from the records of affected Missourians. The largest counties in Missouri are mostly done with the bulk of the review process but it will likely continue well into 2025. Estimates from the Missouri Supreme Court show that counties…

FridayJan 31, 2025 10:00 am

Congressional Researchers Express Uncertainty of Marijuana Reclassification During Trump’s Term

Congressional researchers say they are uncertain whether the previous administration’s tentative plans to reschedule marijuana will advance under President Donald Trump. Former President Biden and his administration had proposed rescheduling marijuana from Schedule I of the Controlled Substances Act (CSA) to Schedule III, but the plans didn’t crystallize before Biden’s term elapsed. With President Trump publicly stating his disapproval of many of Biden’s measures, congressional researchers say it ‘remains to be seen’ how he will handle marijuana rescheduling. The Congressional Research Service (CRS) published a report analyzing various marijuana-specific topics lawmakers could consider when Congress opens for sessions. In addition…

ThursdayJan 30, 2025 10:00 am

Spain is on the Brink of Legalizing Medical Marijuana

Spanish leaders are on the brink of legalizing medical marijuana and allowing tens of millions of adults to access the controversial drug. A Royal Decree that is expected to be signed and delivered before next summer will legalize medical cannabis in the country, adding Spain to the list of over 40 nations that have legalized the drug for either medical or recreational use. But while marijuana enthusiasts in Spain have declared their approval of the move, some critics say the medical marijuana legalization measure is half-baked and could have achieved more. The European Commission received Spain's draft Royal Decree for…

FridayJan 24, 2025 10:00 am

California Data Breach Compromises 380,000 Customers’ Data

A ransomware attack in California has compromised the data of hundreds of thousands of cannabis customers across the state. Stiiizy, a marijuana brand based in California, recently notified 380,000 customers that their data had been compromised in a phishing attack against one of its vendors. The cannabis brand confirmed the alert via a data breach notification to the Maine Attorney General’s Office stating that on November 20, 2024, one of its point-of-sale processing services vendors notified it of a massive data breach at several retail locations. According to the data breach notification, an ‘organized cybercrime group’ was behind the data…

FridayJan 17, 2025 10:00 am

DEA Judge Calls Off Upcoming Cannabis Reclassification Hearing

Efforts to reclassify cannabis at the federal level recently hit a roadblock after a DEA judge canceled the upcoming reclassification meeting. The main agenda at the meeting would have been a proposal seeking to amend federal cannabis laws and reclassify the controversial drug, putting an end to several decades of prohibition. However, the Drug Enforcement Administration judge has effectively delayed the reclassification process for at least three months. The Department of Health and Human Services proposal sought to move cannabis from Schedule I to Schedule III of the CSA, a move that would finally grant America’s state-level marijuana sector access…

ThursdayJan 16, 2025 10:00 am

How Consumer Preferences Could Influence Marijuana Retail This Year

Every cannabis retailer worth their salt makes sure to study consumer preferences and incorporate them into their decision-making processes. Regardless of the sector, taking customer preferences into account helps businesses serve their customers efficiently by providing goods or services that meet an already-established need. With the cannabis industry entering a new year, customer preferences will be a major influencing factor for the industry. Retailers will likely use consumer preference data to determine their inventory and the products they offer in 2025. For instance, pre-rolls have exhibited sustained growth for the past year and could make a major appearance in major…

TuesdayJan 14, 2025 10:00 am

Study Shows Opioid Makers’ Payments to Pain Doctors Dropped After Medical Marijuana Legalization

A multi-institutional study involving researchers from three universities has discovered a correlation between medical cannabis legalization and reduced payments from opioid drug manufacturers to pain doctors. The study found that when states launch regulated medical marijuana programs, patients begin using the divisive drug as an alternative to pharmaceutical pain medications. The result is reduced payments from pain drug manufacturers to doctors who specifically deal with pain and pain-related conditions, say researchers from the State University of New York (SUNY), the University of Southern California, and the University of Florida. According to the researchers, their analysis indicates that pain drug manufacturers…

FridayJan 10, 2025 10:00 am

Medical Cannabis Patients in Arkansas Reach Record Numbers

Voters in Arkansas approved a measure to legalize medical marijuana in 2016 and the state finally began sales in mid-2019 with about 11,000 registered medical marijuana patients. Arkansas’s medical cannabis program has expanded significantly in the years since as more patients registered, reaching 101,006 active MMJ cards in June 2024 and 108,957 by the end of the year. The Arkansas Department of Health is charged with issuing MMJ cards in the state, while the Alcohol and Beverage Control Agency issues licenses to medical cannabis dispensaries. Data shows that post-traumatic stress disorder (PTSD) was the most common medical condition at 34.9%,…

TuesdayJan 07, 2025 10:00 am

Kentuckians Face the Challenge of Choosing Between Gun Ownership and Medical Marijuana

Medical marijuana patients in Kentucky will not have access to guns and ammunition due to federal law. Kentucky's medical marijuana legalization bill was signed into law in March 2023 but took effect on January 1st, 2025, making it legal for approved citizens of the Commonwealth of Kentucky to consume medical-grade cannabis. However, Kentuckians will also have to contend with federal law, which currently outlaws cannabis production and consumption, and how it differs from their state's new medical cannabis law. The U.S. Bureau of Alcohol, Tobacco, Firearms, and Explosives recently sent a letter informing federal firearms licensees that individuals who ‘unlawfully’…